Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensory evaluation for bitterness of asenapine using D-sorbitol pretreatment
jRCTs041210019Completed
- Sponsor
- Meiji Seika Pharma Co., Ltd.
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of asenapine in schizophrenia (2 arms), sponsored by Meiji Seika Pharma Co., Ltd. Primary endpoint: Sensory evaluation for bitterness. Started Jan 2022; status: completed.
02
Drugs
asenapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCTs041210019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210019.